Thomas,
I just went to Biomoda Web site and I pulled the last company Press Release.
It's about the test kit.
Also read post #2737. Gringo called Biomoda and was told they are working 12 to 16 hours a day. WHY?
What's going on?
And as you said in your posts why these high volumes in the last two weeks?
Why also the price dropped on Friday if good news are coming on Monday?
======================================================================
BIOMODA INC.
--------------------------------------------------------------------------------
Press Release Information
--------------------------------------------------------------------------------
FOR IMMEDIATE RELEASE
Contact:
Ari Ma'ayan, President
BioModa Inc.
Phone: 888 848-8594
Email: info@biomoda.com
Web Site: biomoda.com
Medical/Business News
HUMAN CLINICAL TESTING SHOWS VALUE OF NEW DIAGNOSTIC FOR EARLY DETECTION OF LUNG CANCER
[Albuquerque, New Mexico, 11/11/98] BioModa Inc. announced today the successful completion of the first commercial clinical testing of its TCPP lung cancer diagnostic. An independent, commercial lung cytology laboratory performed the tests. The blinded study has proven that BioModa's technology is now ready to move into the commercialization phase. The company expects to have its test kit in the marketplace by the end of the first quarter of 1999.
"This is the validation we've been waiting for. Now it's full speed ahead with the kit" states Ari Ma'ayan, BioModa's President. BioModa had hoped that the testing would validate the company's conclusion from earlier laboratory work that the technology would be capable of detecting early stages of pre-cancerous conditions of the lung. "The trials have done exactly that," said BioModa's Chief Technical Officer, Jeff Garwin, M.D., Ph.D.
"The key to raising the survival rate for any type of cancer is early detection, and up until now there was no test which could accurately, quickly and inexpensively detect patterns of abnormal cells in the lung which could develop into lung cancer. This test should detect those patterns several years before any other diagnostic modality," stated Dr. Garwin. Early detection could raise the 5-year survival rate of lung cancer from 15% to 46%, and new preventive treatments may be able to halt the progression to lung cancer, if pre-cancerous conditions are detected early enough. Lung cancer strikes nearly 200,000 Americans each year and is the leading cause of cancer death in the US and the world.
BioModa's core technology was developed at Los Alamos National Laboratory and St. Mary's Medical Center in Grand Junction, Colorado. BioModa received an exclusive worldwide license to the technology in 1995. The technology is protected by patents, which have issued in the US and several foreign countries and which are pending in several more. Additionally, the company will file a number of important new patents in the near future
BioModa now intends to start developing products to image and treat lung cancer, based on its exclusive core technology. The Company also plans to extend its technology to develop diagnostic tests and treatments for other cancers. Plans call for entering into partnerships with US- and foreign-based corporations for R&D, production, marketing and distribution.
Go Back to the Biomoda Inc. Main Menu
--------------------------------------------------------------------------------
Web pages created, stored, and maintained by Internet Expressions, Inc.
Last Modified: 11/12/98
|
